NEUROFIBROMATOSIS 2
Clinical trials for NEUROFIBROMATOSIS 2 explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS 2 trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug shrink NF2 tumors?
Disease control CompletedThis phase 2 trial tested the drug crizotinib in 12 people with neurofibromatosis type 2 (NF2) who had growing tumors in the ear area called vestibular schwannomas. Participants took crizotinib pills daily for up to 12 months. The main goal was to see if the drug could shrink the…
Matched conditions: NEUROFIBROMATOSIS 2
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Video-Based stress program aims to ease life with neurofibromatosis
Symptom relief CompletedThis study tested two stress and symptom management programs for adults with neurofibromatosis (NF1, NF2, or schwannomatosis). The programs were delivered through live videoconferencing over 8 weekly sessions. Researchers measured changes in quality of life and emotional well-bei…
Matched conditions: NEUROFIBROMATOSIS 2
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC